Author

C. Diehl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

C. F. Pinzan· 3 shared G. H. Goldman· 3 shared P. A. de Castro· 3 shared T. F. dos Reis· 3 shared L. G. Carnero· 2 shared A. S. Ibrahim· 1 shared C. Boone· 1 shared D.-g. Kim· 1 shared

Activity by Year

2024-2024 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

C. F. Pinzan

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Brilacidin, a novel antifungal agent against Cryptococcus neoformans

C. Diehl, C. F. Pinzan, P. A. de Castro, E. Delbaje, L. G. Carnero, E. Sanchez-Leon, K. Bhalla, J. W. Kronstad, D.-g. Kim, T. L. Doering, S. Alkhazraji, N. N. Mishra, A. S. Ibrahim, M. Yoshimura, L. A. V. Isuhuayla, , G. H. Goldman

This paper identifies brilacidin as a novel antifungal agent effective against Cryptococcus neoformans, showing it reduces fungal survival in macrophages and potentiates existing antifungals.

bioRxiv · Apr 10, 2024 · PreprintMicrobiology

Brilacidin, a host defense peptide mimetic, potentiates ibrexafungerp antifungal activity against the human pathogenic fungus Aspergillus fumigatus

T. F. dos Reis, C. Diehl, C. F. Pinzan, P. A. de Castro, G. H. Goldman

This study shows that brilacidin enhances ibrexafungerp's antifungal effect against Aspergillus fumigatus, including strains resistant to caspofungin.

bioRxiv · Apr 5, 2024 · PreprintMicrobiology

Milteforan, a promising veterinary commercial product against feline sporotrichosis

L. G. Carnero, T. F. dos Reis, C. Diehl, P. A. de Castro, L. Pontes, C. F. Pinzan, G. H. Goldman

The paper shows milteforan, a veterinary product containing miltefosine, is effective against sporotrichosis caused by S. brasiliensis and S. schenckii in vitro and in infected cells.

bioRxiv · Feb 14, 2024Microbiology